TSC1 and TSC2 are frequently mutated/deleted in a variety of solid tumors, including lung (22%) and liver (16%) cancers, leading to deregulated PI3K-AKT-mTOR signaling [169,170]. This evidence concerns the gene AKT1 and cancer.